Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/2012
05/23/2012CN101522670B Pyridin-3-yl derivatives as immunomodulating agents
05/23/2012CN101518594B Anti-tumor immunity-enhancing traditional Chinese medicine preparation and preparation method thereof
05/23/2012CN101514192B Quinoxalinone derivative with activity for reversing tumor cell multidrug resistance and preparation method thereof
05/23/2012CN101503369B Method for preparing vanillyl acidamide compounds by interfacial reaction
05/23/2012CN101481401B Tripterygium wilfordii diterpenoid lactone derivative, pharmaceutical composition thereof and use in genital system tumor resistance
05/23/2012CN101467967B Double-element solution type preparation for intravenous injection and intracerebral injection
05/23/2012CN101429251B Antineoplastic amalgamation protein, preparation method and uses thereof
05/23/2012CN101412737B Anti-tumor bipyridine methyl substituted manganese amino acid complex, and preparation and application thereof
05/23/2012CN101407539B Oligopeptide having marrow hemopoiesis protection function, preparation thereof, pharmaceutical composition containing the oligopeptide and use
05/23/2012CN101379060B Benzazole derivatives, compositions, and methods of use as Aurora kinase inhibitors
05/23/2012CN101302236B Novel method for synthesizing antineoplastic medicine nedaplatin
05/23/2012CN101270118B Technique for spherosinin purification with continuous column chromatography
05/23/2012CN101260095B 13-halo-3,15-dioxygibberellic acid ester and preparation method thereof
05/23/2012CN101239100B Application of Sichuan chinaberry extract in pharmaceutical and extracting method thereof
05/23/2012CN101227823B Method for preparing concentration components of tetrahydro tetrahydroxy curcumin and tetrahydroxy curcumin from curcuma extractive
05/23/2012CN101176721B Hexamethylmelamine liposome and preparation method thereof
05/23/2012CN101155800B Pyrazolylaminopyridine derivatives useful as kinase inhibitors
05/23/2012CN101142319B Vaccines based on the use of mv
05/23/2012CN101119978B HSP90-inhibiting triazole derivatives
05/23/2012CN101045046B Use of Brazil hemoatoxy type compound for preparing antineoplastic
05/22/2012US8183405 Obovatol derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical composition for the prevention and treatment of cancer containing the same as an active ingredient
05/22/2012US8183369 4- [3- (4-cyclopropanecarbonyl-piperazine-I-carbonyl) -4 -fluoro-benzyl] -2H-phthalaz in-1-one
05/22/2012US8183363 Antisense oligonucleotide modulation of STAT3 expression
05/22/2012US8183362 Method and medicament for inhibiting the expression of a given gene
05/22/2012US8183361 Oligonucleotide-containing pharmacological compositions and their use
05/22/2012US8183297 Medium and device for proliferation of stem cells and treatment of cancer-related stem cell with resveratrol
05/22/2012US8183295 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
05/22/2012US8183222 Method to inhibit cell growth using oligonucleotides
05/22/2012US8183009 Assaying cellular markers for the evaluation of tumors
05/22/2012CA2681136C Heterocyclic compounds and their uses
05/22/2012CA2540501C Quinoline derivatives and quinazoline derivatives, medicaments containing said compounds, use thereof, and method for the production thereof
05/22/2012CA2508069C Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
05/22/2012CA2492938C Cancer vaccines containing epitopes of oncofetal antigen
05/22/2012CA2491296C Methods for treating psychosis associated with interferon-.alpha. therapy
05/22/2012CA2464947C Combination therapy for treating disease
05/22/2012CA2458442C Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption
05/22/2012CA2449013C Viral mutants that selectively replicate in targeted human cancer cells
05/22/2012CA2440214C Method of modulating the proliferation of medullary thyroid carcinoma cells
05/22/2012CA2436107C Kyberdrug as autovaccines with immune-regulating effects
05/22/2012CA2386865C Diagnosis and therapy of cancer using sgp28-related molecules
05/22/2012CA2374964C Process for producing an injectable medicament preparation
05/22/2012CA2348956C Immunotherapeutic methods using epitopes of wt-1 and gata-1
05/22/2012CA2336717C Immortalized human keratinocyte cell line
05/18/2012WO2012065156A2 Ex vivo development, expansion and in vivo analysis of a novel lineage of dendritic cells
05/18/2012WO2012065139A2 Entpd5 inhibitors
05/18/2012WO2012065106A2 Compounds and related methods for manipulating parp-1-dependent cell death
05/18/2012WO2012065057A2 Phosphatidylinositol 3-kinase inhibitors and methods of their use
05/18/2012WO2012065050A1 22-haloacetoxy-homopregnacalciferol analogs and their uses
05/18/2012WO2012065022A2 Spiro-oxindole mdm2 antagonists
05/18/2012WO2012065021A1 Dexamethasone combination therapy
05/18/2012WO2012065019A2 Pyridopyrimidinone inhibitors of p13k alpha
05/18/2012WO2012064943A2 Metalloenzyme inhibitor compounds
05/18/2012WO2012064914A2 Peptidomimetic inhibitors of psma
05/18/2012WO2012064842A2 System and method for generating micro-seismic events and characterizing properties of a medium with non-linear acoustic interactions
05/18/2012WO2012064824A1 Lipid formulated compositions and methods for inhibiting expression of eg5 and vegf genes
05/18/2012WO2012064815A1 Substituted azaindazole compounds
05/18/2012WO2012064805A1 Salt(s) of 7-cyclopentyl-2 -(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof
05/18/2012WO2012064792A2 Protein complexes for antigen binding and methods of use
05/18/2012WO2012064548A1 Compounds useful for inhibiting chk1
05/18/2012WO2012064286A1 Targeting metabolic enzymes in human cancer
05/18/2012WO2012064159A2 Anticancer composition
05/18/2012WO2012064150A2 Composition comprising benproperine derivatives as active ingredients for preventing and treating angiogenesis-related diseases
05/18/2012WO2012064146A2 Anticancer composition containing gkn 1
05/18/2012WO2012064087A2 Pharmaceutical composition including polymer microsphere containing anastrozole as active ingredient
05/18/2012WO2012063894A1 Compositions containing antisense oligonucleotide to micro rna
05/18/2012WO2012063839A1 Anti single-strand type-iv collagen polypeptide antibody, and pharmaceutical, or agent for diagnosing, preventing or treating tumours, containing same
05/18/2012WO2012063357A1 Method for producing bioactive agent, bioactive agent produced thereby, cosmetic, freshness-maintaining agent, growth promotion agent, soil conditioning agent, and pharmaceutical stock solution
05/18/2012WO2012063250A1 Substituted 4-beta-acrylamidopodophyllotoxin congeners as antitumour antibiotics and the process for preparation thereof
05/18/2012WO2012063134A2 Cardiac glycoside analogs in combination with emodin for cancer therapy
05/18/2012WO2012062920A1 Combination therapy with an antitumor alkaloid
05/18/2012WO2012062906A1 Peptides as bioactive compounds
05/18/2012WO2012062905A2 Chromene derivatives and their analoga as wnt pathway antagonists
05/18/2012WO2012062901A2 Chromene derivatives and their analoga as wnt pathway antagonists
05/18/2012WO2012062694A1 Use of 2-carboxamide cycloamino urea derivatives in the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members
05/18/2012WO2012062653A1 Combination of bevacizumab and 2,2-dimethyl-n-((s)-6-oxo-6,7-dihydro - 5h-dibenzo[b,d]azepin-7-yl)-n'-(2,2,3,3,3-pentafluoro-propyl)-malonamide for the treatment of proliferative disorders
05/18/2012WO2012062218A1 Soluble pd-1 variants, fusion constructs, and uses thereof
05/18/2012WO2012062094A1 Conjugate of folate and antibody, preparation method and use thereof
05/18/2012WO2012062072A1 Human-mouse chimeric monoclonal antibody against angiostatin receptor and use thereof
05/18/2012WO2012062044A1 Small molecule inhibitor syntelin against kinetochore motor protein cenp-e and use thereof
05/18/2012WO2012061954A1 Preparative method and use of zingiberensis saponin extracted from dioscorea zingiberensis with antitumor activity
05/18/2012WO2012037687A9 Therapeutic polypeptides and uses thereof
05/18/2012WO2012037411A9 Estrogen receptor modulators and uses thereof
05/18/2012WO2012024620A3 Autotaxin inhibitors and uses thereof
05/18/2012WO2012021840A3 Materials and methods for designing autologous idiotype vaccines and treatment of b-cell malignancies
05/18/2012WO2012018866A3 Methods and compositions for the diagnosis and treatment of breast cancer
05/18/2012WO2012014085A3 Uses of cimiracemate a and related compounds for treating inflammation and modulating immune responses
05/18/2012WO2012012809A3 APPLICATION OF β-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT
05/18/2012WO2012011741A3 Novel fusarisetin compounds, and use thereof
05/18/2012WO2011159847A3 Receptor tyrosine kinase-like orphan receptor 1 (ror1) single chain fv antibody fragment conjugates and methods of use thereof
05/18/2012CA2825083A1 Conjugate of folate and antibody, preparation method and use thereof
05/18/2012CA2820590A1 Anti single-strand type-iv collagen polypeptide antibody, and pharmaceutical, or agent for diagnosing, preventing or treating tumours, containing same
05/18/2012CA2817710A1 Compositions and methods for the prevention and treatment of cancer
05/18/2012CA2817709A1 Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same
05/18/2012CA2817691A1 Metalloenzyme inhibitor compounds
05/18/2012CA2817585A1 Spiro-oxindole mdm2 antagonists
05/18/2012CA2817568A1 Cancer therapies and diagnostics
05/18/2012CA2817561A1 System and method for generating micro-seismic events and characterizing properties of a medium with non-linear acoustic interactions
05/18/2012CA2817420A1 Combination therapy with an antitumor alkaloid
05/18/2012CA2817331A1 Chromene derivatives and their analoga as wnt pathway antagonists
05/18/2012CA2817223A1 Methods of treating cancer
1 ... 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 ... 2211